NCT03611556 2023-10-03MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.MedImmune LLCPhase 1/2 Completed213 enrolled 42 charts
NCT02392507 2020-11-19A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLCEli Lilly and CompanyPhase 2 Completed54 enrolled 16 charts